Search alternatives:
mm decrease » nn decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
2 decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
12 mm » 10 mm (Expand Search), 2 mm (Expand Search), 15 mm (Expand Search)
mm decrease » nn decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
2 decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
12 mm » 10 mm (Expand Search), 2 mm (Expand Search), 15 mm (Expand Search)
-
1
HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching.
Published 2015“…<p><b>A,B:</b> Gene knockdown of EZH2 and SUZ12 was confirmed by qPCR. <b>C,D:</b> In HRMECs transfected with EZH2 siRNA in HG, miR-200b and VEGF were not significantly different from HG+control siRNA but decreased compared to NG+control siRNA. …”
-
2
Decrease of myopia progression with 0.025% atropine
Published 2018“…Myopic progression was significantly lower in group 1 (-0.43 +/- 0.19 D) than in group 2 (-1.24 +/- 0.37 D) and axial length increase was also significantly smaller in group 1(0.19 +/- 0.09 mm) than in group 2 (0.48 +/- 0.12 mm). …”
-
3
-
4
-
5
-
6
Anesthetics differentially decrease cilia-driven particle transport speed (PTS).
Published 2016“…<b>(B)</b> HEPES (solvent of isoflurane) alone also had no effect on PTS. N = 2 tracheas from 2 animals. <b>(C)</b> Avertin® (0.4 mM) decreased PTS significantly. …”
-
7
-
8
Combined therapeutic treatment with 2ME2 and SD-208 additively decreases bone metastases in mice.
Published 2009Subjects: -
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
Supplementary Material for: Decreasing Attacks and Improving Quality of Life through a Systematic Management Program for Patients with Hereditary Angioedema
Published 2021“…<b><i>Results:</i></b> Mean number of attacks/month significantly decreased (95% credible interval [CrI] excluding 0) from 1.15 preintervention to 0.25 and 0.23, 8 and 14 months within intervention, with mean decreases of −0.89 (95% CrI: −1.21 to −0.58) and −0.92 (95% CrI: −1.22 to −0.60), respectively. …”
-
20